Skip to main content
TipRanks
Go Ultimate75% OFF

Seres Therapeutics (MCRB) Ratios

0 Followers

Seres Therapeutics Ratios

CH:MCRB's free cash flow for Q3 2026 was $-10.48M. For the 2026 fiscal year, CH:MCRB's free cash flow was increased by $0.00 and operating cash flow was $-10.48M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio2.560.941.782.283.69
Quick Ratio2.560.941.482.283.69
Cash Ratio2.370.751.301.902.19
Solvency Ratio0.10-1.12-0.27-0.72-0.27
Operating Cash Flow Ratio0.06-3.61-1.19-2.670.08
Short-Term Operating Cash Flow Coverage0.110.000.00-501.790.00
Net Current Asset Value$ -44.60M$ -87.35M$ -228.05M$ -143.24M$ 80.28M
Leverage Ratios
Debt-to-Assets Ratio0.600.660.550.470.14
Debt-to-Equity Ratio1.886.65-4.4315.080.37
Debt-to-Capital Ratio0.650.871.290.940.27
Long-Term Debt-to-Capital Ratio0.000.001.790.820.16
Financial Leverage Ratio3.1310.14-7.9932.352.70
Debt Service Coverage Ratio0.950.00-13.77-26.39-19.49
Interest Coverage Ratio0.000.00-14.81-29.89-22.16
Debt to Market Cap0.080.000.570.080.03
Interest Debt Per Share9.3711.7933.1231.2011.37
Net Debt to EBITDA3.78-0.51-0.390.002.31
Profitability Margins
Gross Profit Margin-423.83%0.00%0.00%0.00%100.00%
EBIT Margin721.93%0.00%0.00%0.00%-43.24%
EBITDA Margin1245.75%0.00%0.00%0.00%-39.14%
Operating Profit Margin-11910.14%0.00%0.00%0.00%-44.50%
Pretax Profit Margin721.93%0.00%0.00%0.00%-45.25%
Net Profit Margin721.93%0.00%0.00%0.00%-45.25%
Continuous Operations Profit Margin721.93%0.00%0.00%0.00%-45.25%
Net Income Per EBT100.00%116.54%59.81%136.27%100.00%
EBT Per EBIT-6.06%103.67%97.45%102.04%101.68%
Return on Assets (ROA)4.12%-104.84%-31.71%-71.72%-18.48%
Return on Equity (ROE)12.88%-1063.34%253.53%-2319.92%-49.87%
Return on Capital Employed (ROCE)-79.05%-123.05%-75.05%-68.36%-23.66%
Return on Invested Capital (ROIC)-72.70%-113.10%-73.48%-67.32%-23.10%
Return on Tangible Assets4.12%-104.84%-31.71%-71.72%-18.48%
Earnings Yield4.32%-113.50%-63.46%-41.33%-8.58%
Efficiency Ratios
Receivables Turnover2.190.000.000.000.00
Payables Turnover2.460.870.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.010.000.000.004.01
Asset Turnover0.010.000.000.000.41
Working Capital Turnover Ratio0.060.000.000.000.65
Cash Conversion Cycle18.00-421.530.000.000.00
Days of Sales Outstanding166.540.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding148.54421.530.000.000.00
Operating Cycle166.540.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share0.13-19.13-18.34-42.341.46
Free Cash Flow Per Share0.10-19.17-19.58-44.16-0.63
Dividend Paid and CapEx Coverage Ratio4.43-391.08-14.72-23.300.70
Capital Expenditure Coverage Ratio4.43-391.08-14.72-23.300.70
Operating Cash Flow Coverage Ratio0.01-1.62-0.59-1.410.14
Operating Cash Flow to Sales Ratio1.420.000.000.000.05
Free Cash Flow Yield0.66%-115.37%-69.94%-39.43%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio23.25-0.88-1.58-2.42-11.65
Price-to-Sales (P/S) Ratio167.070.000.000.005.27
Price-to-Book (P/B) Ratio2.989.37-4.0056.135.81
Price-to-Free Cash Flow (P/FCF) Ratio152.39-0.87-1.43-2.54-265.42
Price-to-Operating Cash Flow Ratio118.01-0.87-1.53-2.65114.22
Price-to-Earnings Growth (PEG) Ratio-0.22-0.140.03-0.010.32
Enterprise Value Multiple17.20-1.58-1.38-3.54-11.16
Enterprise Value169.02M189.99M250.02M604.79M633.09M
EV to EBITDA17.20-1.58-1.38-3.54-11.16
EV to Sales214.220.000.000.004.37
EV to Free Cash Flow195.40-1.28-1.99-2.53-219.98
EV to Operating Cash Flow151.32-1.28-2.13-2.6494.66
Tangible Book Value Per Share4.991.77-7.012.0028.68
Shareholders’ Equity Per Share4.991.77-7.012.0028.68
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.090.000.000.0031.61
Net Income Per Share0.64-18.86-17.77-46.29-14.30
Tax Burden1.001.170.601.361.00
Interest Burden1.001.001.011.031.05
Research & Development to Revenue62.180.000.000.000.98
SG&A to Revenue49.630.000.000.000.48
Stock-Based Compensation to Revenue13.740.000.000.000.14
Income Quality0.20-1092.711.030.91-0.10

Currency in USD